Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
CONCLUSIONS: High anticholinergic burden contributes to specific cognitive deficits in older individuals with schizophrenia that resemble those commonly observed early in the course of Alzheimer's dementia. The ACB is a potentially useful screening tool that can help identify patients at risk of developing anticholinergic-related cognitive impairment.
PMID: 29188908 [PubMed - as supplied by publisher]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
More News: Alzheimer's | Brain | Dementia | Learning | Men | Neurology | Psychiatry | Schizophrenia | Universities & Medical Training